2025-08145RuleWallet

Bug DNA Storage Gadget Gets FDA Classification

Published Date: 5/9/2025

Rule

Summary

The FDA is officially putting microbial nucleic acid storage and stabilization devices into class II, meaning they’ll have special safety rules but less red tape. This change helps companies bring these devices to market faster while keeping patients safe. It affects manufacturers and healthcare providers starting May 9, 2025, and aims to boost innovation without extra costs.

Analyzed Economic Effects

4 provisions identified: 3 benefits, 1 costs, 0 mixed.

Device moved to Class II (special controls)

The FDA has officially classified microbial nucleic acid storage and stabilization devices as Class II (special controls). The final order is effective May 9, 2025 (the classification was applicable March 19, 2018). FDA says this change will reduce regulatory burdens and help patients get innovative devices faster.

Device subject to 510(k) premarket notification

Under this classification, the device is subject to premarket notification under section 510(k) of the FD&C Act rather than automatic Class III premarket approval. This allows sponsors to use the 510(k) pathway and, when applicable, for this device to serve as a predicate for future 510(k) submissions.

New labeling and validation requirements for makers

Manufacturers must meet specific special controls in 21 CFR 866.2950, including labeling that lists microorganisms and specimen types, a detailed device description, performance data including nucleic acid stability and microorganism inactivation, limiting statements about compatibility and validation scope, and design verification/validation including limit of detection information.

Special controls address false negatives and inactivation risks

FDA identified risks to health such as false negative results from failure to stabilize nucleic acid and risks from failure to inactivate specimens. FDA states that the general controls plus the named special controls will mitigate these risks and provide reasonable assurance of safety and effectiveness.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Rule Effective
5/9/2025
5/9/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register